FDA hints it may crack down on marijuana products that claim health benefits
Published: Oct 3, 2017, 3:12 pm • Updated: Oct 3, 2017, 5:16 pm
By Drew Armstrong and Michelle Fay Cortez, Bloomberg
The U.S. Food and Drug Administration may start cracking down on claims that marijuana has health benefits that haven’t been proven, the agency’s commissioner said Tuesday.
“I see people who are developing products who are making claims that marijuana has antitumor effects in the setting of cancer,” FDA Commissioner Scott Gottlieb said at a hearing before Congress on a separate matter. “It’s a much broader question about where our responsibility is to step into this.”
It’s time to start looking at rules around the plant, which some states have legalized for medicinal or recreational use, the commissioner said.
Related stories
- CBD on the international stage: WHO committee delving into science, control status of cannabis compound
- Federal ban on marijuana has created ‘regulatory vacuum’ says new study
- Op-ed: DEA position statement on CBD, hemp and Farm Bill “reckless and illegal”
“We’ll have some answers to this question very soon because I think we do bear some responsibility to start to address these questions,” Gottlieb said.
Topics: cancer, fda, health, medical marijuana, Scott Gottlieb
